×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Vor Biopharma Inc. (VOR) NASDAQ

$2 (0.07) (-3.15%)

Market Cap: $139.47M

As of 10/04/23 04:00 PM EDT. Market closed.

(VOR)

Vor Biopharma Inc. (VOR)
NASDAQ

$2
(0.07) (-3.15%)

Market Cap: $139.47M

As of 10/04/23 04:00 PM EDT. Market closed.

vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor’s ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from ... read more

vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor’s ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from depletion but leaving tumor cells vulnerable. vor’s platform could potentially be used to change the treatment paradigm of both hematopoietic stem cell transplants and antigen-targeted therapies such as antibody drug conjugates, bispecific antibodies and car-t cell treatments. a proof-of-concept study for vor’s lead program has been published in proceedings of the national academy of sciences. vor is based in cambridge, mass. and has a broad intellectual property base including in-licenses from columbia university, where foundational work was conducted by inventor and vor scientific board chair siddhar read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
159
Address
.
PRICE CHART FOR VOR BIOPHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.15
Previous Close
$2.07
Days Range
$1.97 - $2.15
52 week range
$1.90 - $7.57
Volume
66,029
Avg. Volume (30 days)
81,429
Market Cap
$139.47M
Dividend Yield
-
P/E
-
Shares Outstanding
67,538,680
Open
$2.15
Previous Close
$2.07
Days Range
$1.97 - $2.15
52 week range
$1.90 - $7.57
Volume
66,029
Avg. Volume (30 days)
81,429
Market Cap
$139.47M
Dividend Yield
-
P/E
-
Shares Outstanding
67,538,680
FINANCIAL STATEMENTS FOR VOR BIOPHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VOR BIOPHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Jorgensen Nathan D.Chief Financial OfficerSep 01, 2023 Option Exercise$2.676,31016,848146,481Sep 06, 2023, 04:31 PM
Chakraborty TirthaChief Scientific OfficerSep 01, 2023 Option Exercise$2.675,57614,888134,828Sep 06, 2023, 04:29 PM
ANG ROBERTPresident and CEOSep 01, 2023 Option Exercise$2.6712,65733,794683,286Sep 06, 2023, 04:28 PM
Chakraborty TirthaChief Scientific OfficerAug 07, 2023 Option Exercise$2.678752,336140,404Aug 09, 2023, 04:38 PM
Jorgensen Nathan D.Chief Financial OfficerAug 07, 2023 Option Exercise$2.678342,227152,791Aug 09, 2023, 04:37 PM
Attar Eyal C.Chief Medical OfficerAug 07, 2023 Option Exercise$2.679992,66752,532Aug 09, 2023, 04:31 PM
ANG ROBERTPresident and CEOAug 07, 2023 Option Exercise$2.672,3616,304695,943Aug 09, 2023, 04:29 PM
ANG ROBERTPresident and CEOMay 08, 2023 Option Exercise$4.142,3619,775698,304May 10, 2023, 04:19 PM
Chakraborty TirthaChief Scientific OfficerMay 08, 2023 Option Exercise$4.148753,622141,279May 10, 2023, 04:18 PM
Jorgensen Nathan D.Chief Financial OfficerMay 08, 2023 Option Exercise$4.148343,453153,625May 10, 2023, 04:16 PM
Attar Eyal C.Chief Medical OfficerMay 08, 2023 Option Exercise$4.149694,01253,531May 10, 2023, 04:14 PM
ANG ROBERTPresident and CEOMar 01, 2023 Option Exercise$5.5112,65769,740700,665Mar 02, 2023, 06:39 PM
Chakraborty TirthaChief Scientific OfficerMar 01, 2023 Option Exercise$5.515,57630,724142,154Mar 02, 2023, 06:37 PM
Jorgensen Nathan D.Chief Financial OfficerMar 01, 2023 Option Exercise$5.516,31034,768154,459Mar 02, 2023, 06:35 PM
Jorgensen Nathan D.Chief Financial OfficerMar 01, 2023 Option Exercise$5.516,31034,768154,459Mar 02, 2023, 06:35 PM
RA CAPITAL MANAGEMENT, L.P.DirectorDec 09, 2022 Option Exercise$4.3011,627,90750,000,00220,923,554Dec 09, 2022, 04:32 PM
5AM Ventures VI, L.P.10% OwnerNov 16, 2021 Sale$15.30330,7065,059,8024,595,089Nov 18, 2021, 08:14 PM
PARMAR KUSHDirectorNov 16, 2021 Sale$15.30330,7065,059,8024,595,089Nov 18, 2021, 08:10 PM
Chakraborty TirthaChief Scientific OfficerAug 17, 2021 Option Exercise$1.3617,44623,72720,980Aug 19, 2021, 04:02 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 09, 2021 Buy$18.002,979,56653,632,1888,297,265Feb 09, 2021, 06:25 PM
5AM Ventures VI, L.P.10% OwnerFeb 09, 2021 Buy$18.00555,5559,999,9904,833,959Feb 09, 2021, 06:03 PM
PARMAR KUSHDirectorFeb 09, 2021 Buy$18.00555,5559,999,9904,833,959Feb 09, 2021, 05:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Jorgensen Nathan D.Chief Financial Officer09/01/202316,848
Chakraborty TirthaChief Scientific Officer09/01/202314,888
ANG ROBERTPresident and CEO09/01/202333,794
Chakraborty TirthaChief Scientific Officer08/07/20232,336
Jorgensen Nathan D.Chief Financial Officer08/07/20232,227
Attar Eyal C.Chief Medical Officer08/07/20232,667
ANG ROBERTPresident and CEO08/07/20236,304
ANG ROBERTPresident and CEO05/08/20239,775
Chakraborty TirthaChief Scientific Officer05/08/20233,622
Jorgensen Nathan D.Chief Financial Officer05/08/20233,453
Attar Eyal C.Chief Medical Officer05/08/20234,012
ANG ROBERTPresident and CEO03/01/202369,740
Chakraborty TirthaChief Scientific Officer03/01/202330,724
Jorgensen Nathan D.Chief Financial Officer03/01/202334,768
Jorgensen Nathan D.Chief Financial Officer03/01/202334,768
RA CAPITAL MANAGEMENT, L.P.Director12/09/202250,000,002
5AM Ventures VI, L.P.10% Owner11/16/20215,059,802
PARMAR KUSHDirector11/16/20215,059,802
Chakraborty TirthaChief Scientific Officer08/17/202123,727
RA CAPITAL MANAGEMENT, L.P.Director02/09/202153,632,188
5AM Ventures VI, L.P.10% Owner02/09/20219,999,990
PARMAR KUSHDirector02/09/20219,999,990
Load More Insider Transactions
FUNDS WITH A POSITION IN VOR BIOPHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.22,780,3431.11%0.14%Other
BLACKROCK INC.2,164,7320.00018%362.95%Other
GEODE CAPITAL MANAGEMENT, LLC722,4050.00026%128.65%Other
BAKER BROS. ADVISORS LP633,8480.01%No changeOther
RENAISSANCE TECHNOLOGIES LLC36,4000.00016%28.17%Other
CHANGE IN SHARES OUTSTANDING FOR VOR BIOPHARMA INC
STOCK BUYBACKS FOR VOR BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
1.16%
1Q

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
1.16%
1Q
BUYBACK ANNOUNCEMENT(S) FOR VOR BIOPHARMA INC
LOADING...